Prof. Tomris Ozben of Turkey Elected Next President of the IFCC
By LabMedica International staff writers Posted on 04 Oct 2022 |

The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC, Milano, Italy) has announced the election of Prof. Tomris Ozben, representing the Turkish Biochemical Society (TBS), as its next President. In the election, Prof. Ozben received 45 votes (58%) from the 77 member societies that voted, out of a total of 89 member societies. Her term in office starts on January 2023 and is scheduled to end on December 2026. Other candidates in the election were Prof. Michael Neumaier (German Society for Clinical Chemistry and Laboratory Medicine; DGKL) and Prof. Tahir Pillay (South African Association for Clinical Biochemistry and Laboratory Medicine; SAACB).
Prof. Ozben, EuSpLM, Ph.D., D.Sc., and Specialist in Clinical Biochemistry, currently serves as President of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). She has been Chair or a Member in many Federations, Scientific Organizations, Societies, Committees and Councils. She is the Past-IFCC Treasurer, Past-Chair of the IFCC Congress and Conference Committee, Past-President of the Balkan Clinical Laboratory Federation (BCLF), and Board Member of the IFCC Foundation for Emerging Nations (FEN).
Over her tenure at Akdeniz University (Antalya, Turkey), Prof. Ozben has served as Vice Rector, Director of Research Funds, Chair of the Dept. of Clinical Biochemistry, and Founding Director of Central Laboratory at Akdeniz University Hospital. She worked for more than 10 years in the Ethical Committee of Akdeniz University Hospital and Medical Faculty on themes concerning drug research in clinical trials. She served as Commission Member of the Turkish Ministry of Health for restructuring Medical Education and Teaching, as well as Member-Elect of the Turkish High Educational Council for four years.
Prof. Ozben’s own research interests include identification of early markers for diagnosis and prognosis of cancer, cardiovascular and chronic kidney diseases, diabetes, liquid biopsy, proteomics, oxidative stress and antioxidants in health and disease, impact of apoptosis in cancer therapy, multidrug resistance, nanoparticles, therapeutic drug monitoring, development and validation of new tests, analytical techniques, quality control and management, teaching, mentoring, research, and laboratory management.
Prof. Ozben serves as mentor to numerous graduate students and takes part at Post-Graduate Education Programs (Specialty and PhD) at Akdeniz University, PhD program “Clinical Experimental Medicine” at University of Modena and Reggio Emilia and External Examiner for Post-graduate education at University of Zimbabwe. She has received several awards including Akdeniz University “Outstanding Service” and “Science” awards, AACC Van Slyke Society and AACC TDM/Toxicology Division and AACC’s National Academy of Clinical Biochemistry (NACB) awards.
Prof. Ozben is on the Editorial Board of several scientific journals, and a reviewer for several journals, and scientific projects evaluator for the Italian Ministry for University Education and Research (MIUR; CINECA), Ministry of Science and Environmental Protection of Republic of Serbia, Israel Science Foundation, and the Scientific and Technological Research Council of Turkey (TUBITAK). She has taken part in the organization of several WorldLabs, EuroMedLabs, IFCC General Conference, and FEBS-IUBMB Advanced Courses, Workshops and Young Scientists FORUMs. She has published over 250 manuscripts; several book chapters; edited books published by international publishers, and attended as an invited speaker to more than 300 international conferences.
Related Links:
IFCC
Latest Industry News
- ECCMID Congress Name Changes to ESCMID Global
- Bosch and Randox Partner to Make Strategic Investment in Vivalytic Analysis Platform
- Siemens to Close Fast Track Diagnostics Business
- Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics
- Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems
- Sysmex and CellaVision Expand Collaboration to Advance Hematology Solutions
- BD and Techcyte Collaborate on AI-Based Digital Cervical Cytology System for Pap Testing
- Medlab Middle East 2024 to Address Transformative Potential of Artificial Intelligence
- Seegene and Microsoft Collaborate to Realize a World Free from All Diseases and Future Pandemics
- Medlab Middle East 2024 to Highlight Importance of Sustainability in Laboratories
- Fujirebio and Agappe Collaborate on CLIA-Based Immunoassay
- Medlab Middle East 2024 to Highlight Groundbreaking NextGen Medicine
- bioMérieux Acquires Software Company LUMED to Support Fight against Antimicrobial Resistance
- Roche Acquires LumiraDx's Point of Care Technology for USD 295 Million
- Bruker Acquires IVD Manufacturer ELITech Group and Cell Imaging Company Phasefocus
- AMP Publishes Best Practice Guidance for Slice Testing Approach in Diagnostics
Channels
Clinical Chemistry
view channel
3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more.jpg)
POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more
Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
The conventional methods for measuring free cortisol, the body's stress hormone, from blood or saliva are quite demanding and require sample processing. The most common method, therefore, involves collecting... Read moreMolecular Diagnostics
view channel
Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset
Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more
Blood Test Could Detect HPV-Associated Cancers 10 Years before Clinical Diagnosis
Human papilloma virus (HPV) is known to cause various cancers, including those of the genitals, anus, mouth, throat, and cervix. HPV-associated oropharyngeal cancer (HPV+OPSCC) is the most common HPV-associated... Read moreHematology
view channel
Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more
First 4-in-1 Nucleic Acid Test for Arbovirus Screening to Reduce Risk of Transfusion-Transmitted Infections
Arboviruses represent an emerging global health threat, exacerbated by climate change and increased international travel that is facilitating their spread across new regions. Chikungunya, dengue, West... Read more
POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy
Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more
First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy
Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read moreImmunology
view channel
Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies
Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more
AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell
Current strategies for matching cancer patients with specific treatments often depend on bulk sequencing of tumor DNA and RNA, which provides an average profile from all cells within a tumor sample.... Read more
Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment
Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read moreMicrobiology
view channel
Mouth Bacteria Test Could Predict Colon Cancer Progression
Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more.jpg)
Unique Metabolic Signature Could Enable Sepsis Diagnosis within One Hour of Blood Collection
Sepsis is a life-threatening condition triggered by an extreme response of the body to an infection. It requires immediate medical intervention to prevent potential death or lasting damage.... Read morePathology
view channel
Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse
High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more.jpg)
Unique Hand-Warming Technology Supports High-Quality Fingertip Blood Sample Collection
Warming the hand is an effective way to facilitate blood collection from a fingertip, yet off-the-shelf solutions often do not fulfill laboratory requirements. Now, a unique hand-warming technology has... Read moreTechnology
view channel
New Diagnostic System Achieves PCR Testing Accuracy
While PCR tests are the gold standard of accuracy for virology testing, they come with limitations such as complexity, the need for skilled lab operators, and longer result times. They also require complex... Read more
DNA Biosensor Enables Early Diagnosis of Cervical Cancer
Molybdenum disulfide (MoS2), recognized for its potential to form two-dimensional nanosheets like graphene, is a material that's increasingly catching the eye of the scientific community.... Read more
Self-Heating Microfluidic Devices Can Detect Diseases in Tiny Blood or Fluid Samples
Microfluidics, which are miniature devices that control the flow of liquids and facilitate chemical reactions, play a key role in disease detection from small samples of blood or other fluids.... Read more